Chun Hu
13 Papers
Chun Hu is an academic researcher. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 1, co-authored 6 publications.
Chat about Author
Papers
Astragaloside IV as a novel CXCR4 antagonist alleviates osteoarthritis in the knee of monosodium iodoacetate-induced rats.
Kuangyang Yang,Qian Xie,Tingting Tang,Na Zhao,Jian Liang,Ya-Xin Shen,Ziqi Li,Ben Liu,Jianhai Chen,Wenxiang Cheng,Xueling Bai,Peng Zhang,Qian Liu,Bing Song,Chun Hu,Lichu Liu,Yan Wang +16 more
TL;DR: Astragaloside IV (ASN IV), the predominate phytochemical in Astragalus membranaceus, has been identified as a novel CXCR4 antagonist as mentioned in this paper .
15
Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2
Ming He,Jian-Hui Liang,Yanqing Shen,Jin-Wen Zhang,Yingxue Liu,Kuangyang Yang,Li-Chu Liu,Junyi Wang,Qian Xie,Chun Hu,Xun Song,Yan Ling Wang +11 more
TL;DR: It is demonstrated that glycyrrhizin, the main active ingredient of GlycyRrhizae Radix et Rhizoma, prevents the coronavirus from entering cells by targeting angiotensin-converting enzyme 2 (ACE2).
Coptisine Inhibits Influenza Virus Replication by Upregulating p21
Ming-Feng He,Jian-Hui Liang,Yanqiong Shen,Chao Zhang,Kuangyang Yang,Li-Chu Liu,Qian Xie,Chun Hu +7 more
TL;DR: In this paper , coptisine upregulated the p21 signaling pathway in MDCK cells, which was responsible for its antiviral effects, while leaving the MELK expression unchanged.
4
Novel Benzamide Derivatives with Indole Moiety as Dual-Target Antiviral Agents: Rational Design, Efficient Synthesis, and Potent Anti-Influenza Activity Through Concurrent Binding to PAC Terminal Domain and Viral Nucleoprotein
Chao Zhang,Jia-Bin Li,Yi-Wen Zhang,Yun Tang,Xiao-Fei Yu,Qing-Guang Zhang,Zhe Jin,Shi-Cheng Hou,Pang-Chui Shaw,Chun Hu +9 more
- 01 May 2025
2
Design, synthesis and antibacterial activity of novel 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one derivatives
Shicheng Hou,Tai Li,Jiangqing Yan,Dong Cai,Yang Peng,Haibo Zhang,Feng Tong,Haiming Fan,Xiaoping Liu,Chun Hu +9 more
TL;DR: Novel 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one derivatives with ester, carboxylic acid, and piperazine amide moieties were synthesized and exhibited enhanced antibacterial activity against Staphylococcus aureus and Escherichia coli, with compounds 3g and 4g showing superior activity compared to ciprofloxacin.
2